Drawing for PARTNERS FOR THE PLANET

USPTO serial 79411452

PARTNERS FOR THE PLANET

Reviewed by CopyMark Law Group

Reg. 7998529Status 700Registered
Filing date
Status date
Registration date
Oct 28, 2025
Examiner
NOLASCO-ARIAS, KENNETH E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PARTNERS FOR THE PLANET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allisen Pawlenty

Allisen Pawlenty Coates IP3057 Nutley St. #801Fairfax, VA 22031United States

Goods and services

ClassDescriptionStatusFirst use
037Construction services, namely, the building and installation of pharmaceutical and biopharmaceutical manufacturing facilities; building construction services; construction of pharmaceutical facilities; construction management services, namely, onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaidACTIVE—
040Custom processing and manufacturing of biopharmaceuticals; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaidACTIVE—
042Scientific and technological services, namely, scientific research, analysis and testing in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; research and development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial and technical research, development and analysis services; scientific, industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use and manufacture of biotechnology products; technical project studies in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; biopharmaceutical product development; computer software development, programming and implementation for others; design and development of computer software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; medical and biological research laboratory services; preparation of biological samples for analysis in research laboratories; development of processes for use in the manufacture of products in the biotechnology industry; design services relating to manufacturing plants for the biotechnology industry; information, advice and consultancy in relation to all the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 21, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 10, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 10, 2026FIMPFINAL DISPOSITION PROCESSED—
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 28, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Aug 8, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 8, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 8, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 15, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 15, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 12, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 12, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025DOCKASSIGNED TO EXAMINER—
Dec 6, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 6, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance